Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.

Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma. Am J Manag Care. 2019 Feb;25(2 Spec No.):SP43-SP44 Authors: Amaria R, Caffrey M Abstract PMID: 30776211 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30776211?dopt=Abstract

Source: The American Journal of Managed Care - February 1, 2019 Category: Health Management Authors: Amaria R, Caffrey M Tags: Am J Manag Care Source Type: research

More News: Health Management | Managed Care | Melanoma | Neoadjuvant Therapy | Skin Cancer